T1	Participants 94 140	patients with advanced head and neck carcinoma
T2	Participants 354 442	patients with advanced head and neck squamous cell carcinoma or nasopharyngeal carcinoma
T3	Participants 444 597	Patients with locally advanced or metastatic head and neck squamous cell carcinoma or nasopharyngeal carcinoma not suitable for operation or radiotherapy
T4	Participants 730 774	One hundred and thirty-six eligible patients
T5	Participants 1566 1654	patients with advanced head and neck squamous cell carcinoma or nasopharyngeal carcinoma
